Apple Inc. Stock Falls Friday, Still Outperforms Market

Zynerba Pharmaceuticals Inc

Change company Symbol lookup

Select an option...

ZYNE Zynerba Pharmaceuticals Inc

PDO PIMCO Dynamic Income Opportunities Fund

BOCT Innovator U.S. Equity Buffer ETF™ October

BAC Bank of America Corp

YARIY Yara International ASA

XOM Exxon Mobil Corp

XLF Financial Select Sector SPDR® Fund

XFLT XAI Octagon Floating Rate & Alternative Income Term Trust

WPC WP Carey Inc

WMT WALMART STORES INC

Health Care : Pharmaceuticals | Small Cap Value

Company profile

Zynerba Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders. The Company is engaged in improving the lives of patients and their families living with severe, chronic health conditions, including Fragile X syndrome (FXS), and chromosome 22q11.2 deletion syndrome (22q). It is focused on using cannabinoids for treating behavioral symptoms of FXS and 22q. It is developing Zygel (ZYN002), a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery and manufactured without the presence of tetrahydrocannabinol (THC). It uses a patent protected formulation containing ethanol and propylene glycol as solubilizing agents and Transcutol HP as a permeation enhancer. Zygel is an investigational drug product in development for the potential treatment of behavioral symptoms associated with FXS, 22q, and autism spectrum disorder (ASD).

Apple Inc. Stock Falls Friday, Still Outperforms Market

4:32 pm ET September 15, 2023 (MarketWatch) Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Apple Inc. (AAPL) shed 0.42% to $175.01 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.56% to 13,708.33 and Dow Jones Industrial Average falling 0.83% to 34,618.24.

Apple Inc. closed $23.22 short of its 52-week high ($198.23), which the company reached on July 19th.

Despite its losses, the stock outperformed some of its competitors Friday, as Microsoft Corp. (MSFT) fell 2.50% to $330.22, Alphabet Inc. Cl C (GOOG) fell 0.50% to $138.30, and Alphabet Inc. Cl A (GOOGL) fell 0.51% to $137.40.

Trading volume (107.4 M) eclipsed its 50-day average volume of 57.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

September 15, 2023 16:32 ET (20:32 GMT)